Developing a pressure ulcer risk factor minimum data set and risk assessment framework
Developing a pressure ulcer risk factor minimum data set and risk assessment framework
复制标题
DOI：
10.1111/jan.12444
复制
发表时间：
2014-10-01
影响因子：
3.8
通讯作者：
Nixon, Jane
中科院分区：
文献类型：
--
作者：
Coleman, Susanne;Nelson, E. Andrea;Nixon, Jane
目的同意压疮风险因素最小数据集草案，以支持新的基于证据的风险评估框架的开发。背景最近的系统审查确定需要压疮风险因素最小数据集以及基于证据的压疮风险评估框架的开发和验证。这是通过压疮研究计划 (RP-PG-0407-10056) 进行的，由国家健康研究所资助，分为五个阶段。本文报告了第二阶段，一项共识研究。设计共识研究。方法基于研究与开发/加州大学洛杉矶分校适当性方法的改良名义组技术。其中包括专家组、证据审查以及患者和公众参与服务用户组的观点。数据采集时间为2010年12月至2011年12月。结果对最小数据集的危险因素和评估项目（包括不动、压疮和皮肤状态、灌注、糖尿病、皮肤水分、感觉知觉和营养）达成一致。此外，还制定了包含所有最小数据集项目的风险评估框架草案，包括两阶段评估流程（筛选和详细的全面评估）和决策路径。结论风险评估框架草案将与临床护士进行进一步设计和预测试，以评估和提高其可用性。然后将在临床实践中对其进行评估，以评估其有效性和可靠性。最小数据集将来可用于大规模风险因素研究，为风险评估框架的完善提供信息。
AimTo agree a draft pressure ulcer risk factor Minimum Data Set to underpin the development of a new evidenced-based Risk Assessment Framework.BackgroundA recent systematic review identified the need for a pressure ulcer risk factor Minimum Data Set and development and validation of an evidenced-based pressure ulcer Risk Assessment Framework. This was undertaken through the Pressure UlceR Programme Of reSEarch (RP-PG-0407-10056), funded by the National Institute for Health Research and incorporates five phases. This article reports phase two, a consensus study.DesignConsensus study.MethodA modified nominal group technique based on the Research and Development/University of California at Los Angeles appropriateness method. This incorporated an expert group, review of the evidence and the views of a Patient and Public Involvement service user group. Data were collected December 2010-December 2011.FindingsThe risk factors and assessment items of the Minimum Data Set (including immobility, pressure ulcer and skin status, perfusion, diabetes, skin moisture, sensory perception and nutrition) were agreed. In addition, a draft Risk Assessment Framework incorporating all Minimum Data Set items was developed, comprising a two stage assessment process (screening and detailed full assessment) and decision pathways.ConclusionThe draft Risk Assessment Framework will undergo further design and pre-testing with clinical nurses to assess and improve its usability. It will then be evaluated in clinical practice to assess its validity and reliability. The Minimum Data Set could be used in future for large scale risk factor studies informing refinement of the Risk Assessment Framework.